C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s

Keith Henry; Douglas Kitch; Michael Dube; Robert Zackin; Robert A. Parker; Dennis Sprecher; Scott Hammer; Judith Currier

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s

Keith Henry, Douglas Kitch, Michael Dube, Robert Zackin, Robert A. Parker, Dennis Sprecher, Scott Hammer, Judith Currier

Medicine - Infectious Disease and International

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an average of 42 months of indinavir-based highly active antiretroviral therapy (HAART). Pre-HAART CRP levels were determined for 79 patients, and an additional CRP value was obtained after an average of 31 additional months of HAART in 56. CRP levels were elevated but tended to be stable or decrease with indinavir-based HAART over extended periods of exposure.

Original language	English (US)
Pages (from-to)	2434-2437
Number of pages	4
Journal	AIDS
Volume	18
Issue number	18
State	Published - Dec 3 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

OpenUrl availability

Full text

Cite this

@article{76baef452e4948568d5d3f3173cee492,

title = "C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s",

abstract = "Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an average of 42 months of indinavir-based highly active antiretroviral therapy (HAART). Pre-HAART CRP levels were determined for 79 patients, and an additional CRP value was obtained after an average of 31 additional months of HAART in 56. CRP levels were elevated but tended to be stable or decrease with indinavir-based HAART over extended periods of exposure.",

author = "Keith Henry and Douglas Kitch and Michael Dube and Robert Zackin and Parker, {Robert A.} and Dennis Sprecher and Scott Hammer and Judith Currier",

year = "2004",

month = dec,

day = "3",

language = "English (US)",

volume = "18",

pages = "2434--2437",

journal = "AIDS",

issn = "0269-9370",

publisher = "Lippincott Williams and Wilkins",

number = "18",

}

TY - JOUR

T1 - C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen

T2 - AIDS Clinical Trials Group 5056s

AU - Henry, Keith

AU - Kitch, Douglas

AU - Dube, Michael

AU - Zackin, Robert

AU - Parker, Robert A.

AU - Sprecher, Dennis

AU - Hammer, Scott

AU - Currier, Judith

PY - 2004/12/3

Y1 - 2004/12/3

N2 - Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an average of 42 months of indinavir-based highly active antiretroviral therapy (HAART). Pre-HAART CRP levels were determined for 79 patients, and an additional CRP value was obtained after an average of 31 additional months of HAART in 56. CRP levels were elevated but tended to be stable or decrease with indinavir-based HAART over extended periods of exposure.

AB - Ninety-nine durably suppressed HIV-infected patients had a coronary artery disease risk assessment and C-reactive protein (CRP) levels measured after an average of 42 months of indinavir-based highly active antiretroviral therapy (HAART). Pre-HAART CRP levels were determined for 79 patients, and an additional CRP value was obtained after an average of 31 additional months of HAART in 56. CRP levels were elevated but tended to be stable or decrease with indinavir-based HAART over extended periods of exposure.

UR - http://www.scopus.com/inward/record.url?scp=11244341468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11244341468&partnerID=8YFLogxK

M3 - Article

C2 - 15622323

AN - SCOPUS:11244341468

SN - 0269-9370

VL - 18

SP - 2434

EP - 2437

JO - AIDS

JF - AIDS

IS - 18

ER -

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s

Abstract

UN SDGs

OpenUrl availability

Other files and links

Fingerprint

Cite this